Literature DB >> 10689119

HLA-DR and -DQ associations with insulin-dependent diabetes mellitus in a population of Turkey.

G Saruhan-Direskeneli1, F A Uyar, F Bas, H Günöz, R Bundak, N Saka, F Darendeliler.   

Abstract

Genetic susceptibility to insulin-dependent diabetes mellitus (IDDM) has been shown to be associated with MHC in many studies. To extend this data with a population with relatively low IDDM incidence, MHC DRB, DQA, and DQB have been investigated by polymerase chain reaction and sequence specific oligonucleotide probe hybridization (PCR/SSO) in 178 IDDM patients from Turkey and compared to 248 healthy controls. Significant differences are detected between IDDM and control groups in the frequencies of DRB1*0402 DQA1*03 DQB1*0302 (28.1% vs. 5.2%, p < 0.0001, OR: 7.1) and DRB1*0301 DQA1*0501 DQB1*02 (57% vs. 18.1%, p < 0.0001, OR: 6.1). Among the negative associations, the most strong ones are with DRB1*1401 DQA1*0101 DQB1*0503 (0.6% vs. 8.9%, p < 0.0001, OR: 0.1), DRB1*1502 DQA1*0103 DQB1*0601 (1.1% vs. 7.7%, p = 0.0023, OR: 0.1), DRB1*1301 DQA1*0103 DQB1*0603 (0.6% vs. 6.9%, p = 0.0039, OR: 0.2) and DRB1*1101 DQA1*0501 DQB1*0301 (3.9% vs. 12.1%, p < 0.0001, OR: 0.2). When the DRB, DQA or DQB genotypes of the susceptible alleles are compared, the most strong susceptibility marker of the disease is found to be DRB1*0301/*04 (31.4% vs. 2.8%, p < 0.0001, OR: 15.8) and among these, heterozygote genotype DRB1*0301/*0401 (4.5% vs. 0, p = 0.0008, OR: 24.8). These results confirm the positive associations with IDDM previously observed in other Caucasian populations and reveal many negative and strong associations which maybe underlining several characteristics that distinguish Turkish diabetics form other Caucasians.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10689119     DOI: 10.1016/s0198-8859(99)00182-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients.

Authors:  Einas M Al-Harbi; Abdul-Jabbar Abbassi; Hala Tamim; Fayza al-Jenaidi; Mariam Kooheji; Madeeha Kamal; Salwa al-Mahroos; Faisal al-Nasir; Ayesha A Motala; Wassim Y Almawi
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

2.  Prevalence of Autoantibodies and HLA DR, DQ in Type 1 Diabetes Mellitus.

Authors:  Shailja Singh; Gyanendra Singh; Neeraj Kumar Agrawal; Rana Gopal Singh; Shashi Bhushan Kumar
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 3.  Genetics of the HLA region in the prediction of type 1 diabetes.

Authors:  Janelle A Noble; Ana M Valdes
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

4.  Immunogenetic Study of Diabetes Mellitus in Relation to HLA DQ and DR.

Authors:  Gyanendra Singh; Usha Singh; S K Singh; Shailja Singh
Journal:  Indian J Endocrinol Metab       Date:  2020-08-27

5.  HLA-DQB1* alleles and genetic susceptibility to type 1 diabetes mellitus.

Authors:  Youssef M Mosaad; Fatma A Auf; Shereen S Metwally; Ashraf A Elsharkawy; Amany K El-Hawary; Rasha H Hassan; Ziyad E Tawhid; Farha A El-Chennawi
Journal:  World J Diabetes       Date:  2012-08-15

Review 6.  Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

Authors:  Sarah D de Ferranti; Ian H de Boer; Vivian Fonseca; Caroline S Fox; Sherita Hill Golden; Carl J Lavie; Sheela N Magge; Nikolaus Marx; Darren K McGuire; Trevor J Orchard; Bernard Zinman; Robert H Eckel
Journal:  Diabetes Care       Date:  2014-08-11       Impact factor: 19.112

7.  Trends in the frequency of HLA DR-DQ haplotypes among children and adolescents with type 1 diabetes mellitus in the Southeast Region of Turkey.

Authors:  Mehmet Keskin; Ayşe Aygün; Sacide Pehlivan; Özlem Keskin; Yılmaz Kor; Ayşe Balat; Yavuz Coşkun
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.